Cargando…

Antiretroviral Drug-Resistance Mutations on the Gag Gene: Mutation Dynamics during Analytic Treatment Interruption among Individuals Experiencing Virologic Failure

We describe drug-resistance mutation dynamics of the gag gene among individuals under antiretroviral virologic failure who underwent analytical treatment interruption (ATI). These mutations occur in and around the cleavage sites that form the particles that become the mature HIV-1 virus. The study i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hunter, James R., dos Santos, Domingos E. Matos, Munerato, Patricia, Janini, Luiz Mario, Castelo, Adauto, Sucupira, Maria Cecilia, Truong, Hong-Ha M., Diaz, Ricardo Sobhie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145614/ https://www.ncbi.nlm.nih.gov/pubmed/35631055 http://dx.doi.org/10.3390/pathogens11050534

Ejemplares similares

Fitness Cost of Antiretroviral Drug Resistance Mutations on the pol Gene during Analytical Antiretroviral Treatment Interruption among Individuals Experiencing Virological Failure
por: Hunter, James R., et al.
Publicado: (2021)

Characteristics and Outcomes of Initial Virologic Suppressors during Analytic Treatment Interruption in a Therapeutic HIV-1 gag Vaccine Trial
por: Li, Jonathan Z., et al.
Publicado: (2012)

Laboratory surrogate markers of residual HIV replication among distinct groups of individuals under antiretroviral therapy
por: Giron, Leila Bertoni, et al.
Publicado: (2019)

The Virological and Immunological Characteristics of the HIV-1-Infected Population in Brazil: From Initial Diagnosis to Impact of Antiretroviral Use
por: Diaz, Ricardo Sobhie, et al.
Publicado: (2015)

Survival among antiretroviral-experienced HIV-2 patients experiencing virologic failure with drug resistance mutations in Cote d’Ivoire West Africa
por: Tchounga, Boris K., et al.
Publicado: (2020)

Plasma Metabolomics Biosignature According to HIV Stage of Infection, Pace of Disease Progression, Viremia Level and Immunological Response to Treatment
por: Scarpelini, Bruno, et al.
Publicado: (2016)

Correction: Plasma Metabolomics Biosignature According to HIV Stage of Infection, Pace of Disease Progression, Viremia Level and Immunological Response to Treatment
por: Scarpellini, Bruno, et al.
Publicado: (2017)

HIV-1 Gag mutations alone are sufficient to reduce darunavir susceptibility during virological failure to boosted PI therapy
por: Blanch-Lombarte, Oscar, et al.
Publicado: (2020)

Detection of resistance mutations and CD4 slopes in individuals experiencing sustained virological failure
por: Schultze, Anna, et al.
Publicado: (2014)

Cryptococcal Antigenemia in Human Immunodeficiency Virus Antiretroviral Therapy–Experienced Ugandans With Virologic Failure
por: Mpoza, Edward, et al.
Publicado: (2019)

Antiretroviral Genotypic Resistance Mutations in HIV-1 Infected Korean Patients with Virologic Failure
por: Chin, Bum Sik, et al.
Publicado: (2009)

Virological Outcome Measures During Analytical Treatment Interruptions in Chronic HIV-1-Infected Patients
por: Fehér, Csaba, et al.
Publicado: (2019)

Factors Affecting Virological Outcome When First-Line Antiretroviral Therapy Is Reintroduced After Unplanned Interruption
por: Maria, Suzy, et al.
Publicado: (2020)

Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological rebound
por: Zacharopoulou, P., et al.
Publicado: (2022)

2487. Low Rate of Virologic Failure in Antiretroviral Experienced Patients Prescribed Once Daily Raltegravir
por: Hsu, Ricky, et al.
Publicado: (2019)

Dolutegravir-associated resistance mutations after first-line treatment failure in Brazil
por: Diaz, Ricardo Sobhie, et al.
Publicado: (2023)

Immune correlates of CD4 decline in HIV-infected patients experiencing virologic failure before undergoing treatment interruption
por: Huang, Kenneth H, et al.
Publicado: (2008)

Analysis of HIV-1 Protease Gene Reveals Frequent Multiple Infections Followed by Recombination among Drug Treated Individuals Living in São Paulo and Santos, Brazil
por: Nunes, Edsel Renata De Morais, et al.
Publicado: (2014)

The Influence of HIV-1 Subtype in the Response to Therapeutic Dendritic Cell Vaccine
por: Ferreira, Valéria, et al.
Publicado: (2012)

978. Changes in BMI Associated with Antiretroviral Regimens in Treatment-Experienced, Virologically Suppressed Individuals Living with HIV
por: Mounzer, Karam, et al.
Publicado: (2019)

Gag Mutations Strongly Contribute to HIV-1 Resistance to Protease Inhibitors in Highly Drug-Experienced Patients besides Compensating for Fitness Loss
por: Dam, Elisabeth, et al.
Publicado: (2009)

2502. Impact of Pharmacist-Led Antiretroviral Therapy Simplification Initiative in Heavily Treatment-Experienced Patients on Virologic Control
por: Jimenez, Humberto R, et al.
Publicado: (2019)

HIV Drug Resistance Mutations Detection by Next-Generation Sequencing during Antiretroviral Therapy Interruption in China
por: Li, Miaomiao, et al.
Publicado: (2021)

Reviewing HIV-1 Gag Mutations in Protease Inhibitors Resistance: Insights for Possible Novel Gag Inhibitor Designs
por: Su, Chinh Tran-To, et al.
Publicado: (2019)

Virological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation
por: Jose, S, et al.
Publicado: (2015)

Genetic Diversity and Acquired Drug Resistance Mutations Detected by Deep Sequencing in Virologic Failures among Antiretroviral Treatment Experienced Human Immunodeficiency Virus-1 Patients in a Pastoralist Region of Ethiopia
por: Tachbele, Erdaw, et al.
Publicado: (2021)

Applications of Deep Mutational Scanning in Virology
por: Burton, Thomas D., et al.
Publicado: (2021)

Antiretroviral Therapy Interruption (ATI) in HIV-1 Infected Patients Participating in Therapeutic Vaccine Trials: Surrogate Markers of Virological Response
por: Leal, Lorna, et al.
Publicado: (2020)

Prevalence of HIV drug-resistance mutations in HIV-infected Mexican patients heavily experienced to antiretroviral therapy
por: Gaytán-Martínez, JE, et al.
Publicado: (2010)

Genetic Diversity and Acquired Drug Resistance Mutations Detected by Deep Sequencing in Virologic Failures Among Antiretroviral Treatment Experienced Human Immunodeficiency Virus-1 Patients in a Pastoralist Region of Ethiopia [Corrigendum]
Publicado: (2021)

Effect of analytical treatment interruption and reinitiation of antiretroviral therapy on HIV reservoirs and immunologic parameters in infected individuals
por: Clarridge, Katherine E., et al.
Publicado: (2018)

High prevalence and incidence of HIV-1 in a counseling and testing center in the city of Itajaí, Brazil
por: Grinberg, Gorki, et al.
Publicado: (2015)

Nucleocapsid Promotes Localization of HIV-1 Gag to Uropods That Participate in Virological Synapses between T Cells
por: Llewellyn, G. Nicholas, et al.
Publicado: (2010)

Sequential trafficking of Env and Gag to HIV-1 T cell virological synapses revealed by live imaging
por: Wang, Lili, et al.
Publicado: (2019)

Uniquely altered transcripts are associated with immune preservation in HIV infection
por: Zanoni, Michelle, et al.
Publicado: (2017)

Latency-associated DNA methylation patterns among HIV-1 infected individuals with distinct disease progression courses or antiretroviral virologic response
por: Mantovani, Nathalia, et al.
Publicado: (2021)

Intracellular HIV-1 Gag localization is impaired by mutations in the nucleocapsid zinc fingers
por: Grigorov, Boyan, et al.
Publicado: (2007)

Virologic suppression in patients with a documented M184V/I mutation based on the number of active agents in the antiretroviral regimen
por: Mouradjian, Mallory T, et al.
Publicado: (2020)

Two‐drug antiretroviral regimens: an assessment of virologic response and durability among treatment‐experienced persons living with HIV in the OPERA(®) Observational Database
por: Pierone, Gerald, et al.
Publicado: (2019)

Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients
por: Goepfert, Paul A., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_vbr2gh13vttio8f3jco19dptu4